Taylor & Francis acquired the Molecular and Cellular Biology (MCB) journal from the American Society for Microbiology (ASM). ASM is one of the world's oldest and largest single life science membership societies. The editorial and financial transactions were completed at the end of November.
Molecular and Cellular Biology is a monthly, peer-reviewed scientific journal established by ASM in 1981. MCB's scope is rigorous. It includes mechanistic studies that advance significantly in gene expression and genome organization, cellular morphology and function, molecular metabolism, cellular trafficking, and signal transduction. The journal also focuses on studies investigating molecular, cellular, and systemic host responses to pathogenic agents in chronic diseases and conditions.
MCB will be added to Taylor & Francis' life sciences and medical portfolio. The portfolio includes more than 250 journals in Biomedical and Life Sciences. Furthermore, the portfolio has 46 journals in Cell and Molecular Biology, with journals such as Autophagy, Cell Cycle, RNA Biology, Epigenetics, Virulence, and Critical Reviews in Biochemistry and Molecular Biology.
ASM and Taylor & Francis are committed to making this a seamless transition for the authors. Furthermore, Taylor & Francis will start accepting author submissions on December 5, 2022, following the transition from ASM on December 1, 2022.
Click here to read the original press release.
